Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Koo DH"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10).
    Autorzy:
    Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
    Zang DY; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
    Ryu MH; Department of Oncology, Asan Medical Center, Seoul, Korea.
    Han HS; Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.
    Kim KH; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
    Kim MJ; Division of Oncology and Hematology, Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.; Center for Gastric Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
    Koh SA; Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea.
    Lee SS; Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
    Koo DH; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Ko YH; Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Sohn BS; Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea.
    Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
    Park JH; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
    Nam BH; HERINGS, The Institution of Advanced Clinical & Biomedical Research, Seoul, Korea.
    Choi IS; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1250-1260. Date of Electronic Publication: 2023 May 25.
    Typ publikacji:
    Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
    MeSH Terms:
    Stomach Neoplasms*/pathology
    Aged ; Humans ; Capecitabine ; Oxaliplatin/adverse effects ; Cisplatin ; Neoplasm Recurrence, Local/drug therapy ; Fluorouracil/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Molecular Chaperones/therapeutic use ; Tumor Suppressor Proteins
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy.
    Autorzy:
    Won YW; Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
    Kang JH; Division of Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Kwon JH; Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea.
    Koo DH; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Kang JH; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea.
    Maeng CH; Division of Oncology and Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
    Ahn HK; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
    Oh SY; Division of Hematology and Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
    Lee DW; Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
    Sohn J; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
    Oh SY; Division of Hematology and Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan University College of Medicine, Yangsan, Korea.
    Lee KH; Division of Hematology and Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea.
    Koh SJ; Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea.
    Lee KS; Center for Breast Cancer, Research Institute, National Cancer Center, Goyang, Korea.
    Kim CK; Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon, Korea.
    Kim JY; Division of Hematology and Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Ji JH; Division of Hematology and Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
    Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Ha JY; Division of Hematology and Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
    Kim HY; Division of Hematology and Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1096-1103. Date of Electronic Publication: 2023 Apr 07.
    Typ publikacji:
    Observational Study; Multicenter Study; Journal Article
    MeSH Terms:
    Antineoplastic Agents*/adverse effects
    Breast Neoplasms*/drug therapy
    Humans ; Female ; Docetaxel/adverse effects ; Ethanol/adverse effects ; Prospective Studies ; Patients ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting.
    Autorzy:
    Koo DH; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Lee MY; Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Seoul, Korea.
    Chae H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Kim EJ; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Moon MS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2021 Apr; Vol. 53 (2), pp. 436-444. Date of Electronic Publication: 2020 Oct 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antineoplastic Agents/*therapeutic use
    Receptor, ErbB-2/*therapeutic use
    Stomach Neoplasms/*drug therapy
    Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Time Factors ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting.
    Autorzy:
    Kang JH; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea.
    Kwon JH; Division of Hemato-Oncology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
    Lee YG; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Park KU; Division of Hematology/Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
    An HJ; Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
    Seol YM; Division of Hemato-Oncology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
    Lee H; Department of Hematology-Oncology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
    Yun HJ; Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
    Ahn JS; Division of Hematology & Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Yang JH; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea.
    Song H; Division of Hemato-Oncology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
    Koo DH; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Kim JY; Division of Hematology/Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
    Kim GM; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
    Kim HJ; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2020 Jul; Vol. 52 (3), pp. 907-916. Date of Electronic Publication: 2020 Mar 18.
    Typ publikacji:
    Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Quality of Life*
    Antiemetics/*therapeutic use
    Antineoplastic Combined Chemotherapy Protocols/*adverse effects
    Nausea/*drug therapy
    Neoplasms/*drug therapy
    Vomiting/*drug therapy
    Adult ; Aged ; Aprepitant/therapeutic use ; Benzimidazoles/therapeutic use ; Dexamethasone/therapeutic use ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nausea/chemically induced ; Nausea/pathology ; Neoplasms/pathology ; Palonosetron/therapeutic use ; Prognosis ; Prospective Studies ; Surveys and Questionnaires ; Vomiting/chemically induced ; Vomiting/pathology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.
    Autorzy:
    Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
    Kim JG; Department of Oncology/Hematology, School of Medicine, Kyungpook National University, Daegu, Korea.
    Kang BW; Department of Oncology/Hematology, School of Medicine, Kyungpook National University, Daegu, Korea.
    Chung IJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, Korea.
    Hong YS; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
    Song HS; Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University College of Medicine, Daegu, Korea.
    Lee KH; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
    Zang DY; Department of Internal Medicine, Hallym University Medical Center, Hallym University, Anyang, Korea.
    Ko YH; Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
    Song EK; Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea.
    Baek JH; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
    Koo DH; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Oh SY; Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University College of Medicine, Yangsan, Korea.
    Cho H; Medical Department of Genzyme, Sanofi Korea, Seoul, Korea.
    Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2019 Jan; Vol. 51 (1), pp. 223-239. Date of Electronic Publication: 2018 Oct 19.
    Typ publikacji:
    Journal Article; Multicenter Study; Observational Study
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Palliative Care/*psychology
    Quality of Life/*psychology
    Stomach Neoplasms/*drug therapy
    Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Palliative Care/methods ; Prospective Studies ; Republic of Korea ; Stomach Neoplasms/psychology ; Survival Analysis ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Practice Patterns Regarding Multidisciplinary Cancer Management and Suggestions for Further Refinement: Results from a National Survey in Korea.
    Autorzy:
    Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Oh S; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Kimm H; Institute for Health Promotion and Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea.
    Koo DH; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Kim DY; Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
    Kim BS; Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea.
    Lee SS; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2017 Oct; Vol. 49 (4), pp. 1164-1169. Date of Electronic Publication: 2017 Feb 22.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Patient Care Team*
    Practice Patterns, Physicians'*
    Neoplasms/*epidemiology
    Adult ; Aged ; Clinical Decision-Making ; Disease Management ; Female ; Health Care Surveys ; Humans ; Insurance, Health, Reimbursement ; Male ; Middle Aged ; Neoplasms/diagnosis ; Neoplasms/therapy ; Quality Improvement ; Republic of Korea/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.
    Autorzy:
    Koo DH; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Korean GIST Study Group, Seoul, Korea.
    Ryu MH; Korean GIST Study Group, Seoul, Korea.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Kim KM; Korean GIST Study Group, Seoul, Korea.; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Yang HK; Korean GIST Study Group, Seoul, Korea.; Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
    Sawaki A; Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.; Japanese GIST Subcommittee, Nishinomiya, Japan.
    Hirota S; Japanese GIST Subcommittee, Nishinomiya, Japan.; Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan.
    Zheng J; Department of Pathology, Peking University Third Hospital, Beijing, China.; Chinese Expert Committee on GIST, Sichuan, China.
    Zhang B; Chinese Expert Committee on GIST, Sichuan, China.; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Sichuan, China.
    Tzen CY; Department of Pathology and Laboratory Medicine, Cathay General Hospital, Taipei, Taiwan.
    Yeh CN; Department of Surgery, Chang Gung Memorial Hospital and University, Taoyuan, Taiwan.
    Nishida T; Japanese GIST Subcommittee, Nishinomiya, Japan.; Department of Surgery, National Cancer Center Hospital East, Chiba, Japan.
    Shen L; Chinese Expert Committee on GIST, Sichuan, China.; Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
    Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
    Kang YK; Korean GIST Study Group, Seoul, Korea.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2016 Oct; Vol. 48 (4), pp. 1155-1166. Date of Electronic Publication: 2016 Jun 24.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Disease Management*
    Molecular Targeted Therapy*
    Gastrointestinal Stromal Tumors/*diagnosis
    Gastrointestinal Stromal Tumors/*therapy
    Asian People/genetics ; China ; Consensus ; Gastrointestinal Stromal Tumors/pathology ; Guidelines as Topic ; Humans ; Republic of Korea ; Taiwan
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies